Inventor
MONTALBAN ANTONIO GARRIDO
US23 patents
⚠️ This page may combine multiple inventors who share the name “MONTALBAN ANTONIO GARRIDO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARENA PHARM INC
17 patentsUS11091435B2Aug 17, 2021
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1P1 receptor-associated disorders
ARENA PHARM INC11 citations93
US10676435B2Jun 9, 2020
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disorders
ARENA PHARM INC12 citations93
US10301262B2May 28, 2019
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders
ARENA PHARM INC11 citations91
US9447041B2Sep 20, 2016
Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof
ARENA PHARM INC12 citations91
US9175320B2Nov 3, 2015
Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof
ARENA PHARM INC15 citations91
US10981895B2Apr 20, 2021
Crystalline forms and processes for the preparation of cannabinoid receptor modulators
ARENA PHARM INC4 citations84
US10183930B2Jan 22, 2019
Crystalline forms and processes for the preparation of cannabinoid receptor modulators
ARENA PHARM INC10 citations84
US11149292B2Oct 19, 2021
Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof
ARENA PHARM INC8 citations83
US10632134B2Apr 28, 2020
Cannabinoid receptor modulators
ARENA PHARM INC5 citations83
US9867822B2Jan 16, 2018
Cannabinoid receptor modulators
ARENA PHARM INC7 citations83
US9492447B2Nov 15, 2016
Cannabinoid receptor modulators
ARENA PHARM INC9 citations83
US11771695B2Oct 3, 2023
Cannabinoid receptor modulators
ARENA PHARM INC4 citations74
US11884626B2Jan 30, 2024
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disorders
ARENA PHARM INC3 citations73
US11560369B2Jan 24, 2023
Crystalline forms and processes for the preparation of cannabinoid receptor modulators
ARENA PHARM INC2 citations73
US12109219B2Oct 8, 2024
Cannabinoid receptor modulators
ARENA PHARM INC0 citations62
US12378198B2Aug 5, 2025
Crystalline l-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in SIPI receptor-associated disorders
ARENA PHARM INC0 citations61
US11674163B2Jun 13, 2023
Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
ARENA PHARM INC0 citations61